IONS — IONIS PHARMACEUTICALS INC

Ownership history in Entropy Technologies, LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Entropy Technologies, LP reported a position in IONIS PHARMACEUTICALS INC (IONS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.16% (2025 Q3)
Avg. % of fund
0.11%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 32,925 +3,473 +11.8% 0.16% $2.2M $65.42
2025 Q2 ADDED 29,452 +14,910 +102.5% 0.09% $1.2M $39.51
2024 Q1 INITIATED 14,542 — — 0.07% $630K —
% of Fund (quarterly)    IONS price (monthly, adj. close)

Other funds also holding IONS

As of 2025 Q4 — sorted by position size

Tweedy, Browne Co LLC 3Y 7Y 15.74% BOONE CAPITAL MANAGEMENT LLC 3Y 10.37% Bellevue Group AG 3Y 7Y 7.2% Tri Locum Partners LP 3Y 5.72% Orion Investment Co 5.43% Exome Asset Management LLC 4.41% Privium Fund Management B.V. 3Y 3.51% Sicart Associates LLC 3Y 7Y 3.43% SECTOR GAMMA AS 3Y 7Y 3.34% SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 3Y 7Y 2.41%
← Back to Entropy Technologies, LP Holdings